Results 31 to 40 of about 8,489 (240)

Decrease in tick bite consultations and stabilization of early Lyme borreliosis in the Netherlands in 2014 after 15 years of continuous increase

open access: yesBMC Public Health, 2016
Background Nationwide surveys have shown a threefold increase in general practitioner (GP) consultations for tick bites and early Lyme borreliosis from 1994 to 2009 in the Netherlands.
Agnetha Hofhuis   +6 more
doaj   +1 more source

Mini erythema migrans - A sign of early Lyme borreliosis [PDF]

open access: yes, 2006
Background: An erythema migrans (EM) remaining smaller than 5 cm in diameter, called mini EM by us, has not been addressed in detail. Objective: To study the significance of the mini EM as a sign of Lyme borreliosis. Methods: Patients with suspected mini
Weber, K., Wilske, B.
core   +1 more source

Bull’s-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans

open access: yesDermatology Research and Practice, 2012
Introduction. Lyme disease is an emerging worldwide infectious disease with major foci of endemicity in North America and regions of temperate Eurasia.
John N. Aucott   +3 more
doaj   +1 more source

Erythema caused by a localised skin infection with Arthrobacter mysorens

open access: yesBMC Infectious Diseases, 2010
Background Skin erythemas of unknown origin are a frequent reason for consulting the general practitioner or dermatologist. Case presentation Here we report a case of an erythema resembling the erythema migrans manifestation of Lyme disease, but with ...
Chakraborty Trinad   +4 more
doaj   +1 more source

Lyme Disease among Patients at an Ambulatory Unit in a Highly Endemic Country: Lithuania

open access: yesMedicina, 2021
Background and objectives: Lyme disease is the most common tick-borne infectious disease in Europe, caused by the spirocheta bacteria of Borrelia burgdorferi. Several genospecies of B. burgdorferi are pathogenic to humans. B.
Agnė Petrulionienė   +3 more
doaj   +1 more source

Clinical and laboratory characteristics of diseases caused by Borrelia spp. in the inhabitants of the Novosibirsk region in 2015–2017

open access: yesЖурнал инфектологии, 2018
The aim of the study was to establish the clinical and laboratory  features of Lyme borreliosis (LB) and borreliosis caused by Borrelia miyamotoi in adults from Novosibirsk region.Materials and methods.
M. V. Savel’eva   +6 more
doaj   +1 more source

The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis [PDF]

open access: yes, 2018
Lyme borreliosis (LB) is the most common tick-borne disease caused by the spirochete Borrelia burgdorferi in North America and Borrelia afzelii or Borrelia garinii in Europe and Asia, respectively.
Bordignon, Valentina   +10 more
core   +2 more sources

Treatment of Erythema Migrans in Pregnancy [PDF]

open access: yesClinical Infectious Diseases, 1996
The course of the illness and the outcome of pregnancy were investigated in a prospective study of 58 consecutively enrolled pregnant women with typical erythema migrans at the University Medical Centre of Ljubljana, Slovenia. Thirteen patients (22.4%) acquired borrelial infection in the first trimester of pregnancy, 27 (46.6%) in the second trimester,
J Cimperman   +4 more
openaire   +3 more sources

Diagnostic challenges of early Lyme disease: Lessons from a community case series

open access: yesBMC Infectious Diseases, 2009
Background Lyme disease, the most common vector-borne infection in North America, is increasingly reported. When the characteristic rash, erythema migrans, is not recognized and treated, delayed manifestations of disseminated infection may occur.
Schwarzwalder Alison   +5 more
doaj   +1 more source

Successful Amplification of DNA Specific for Finnish Borrelia burgdorferi Isolates in Erythema Chronicum Migrans but Not in Circumscribed Scleroderma Lesions [PDF]

open access: yes, 1994
Early diagnosis of Borrelia burgdorferi infection, hampered by the absence of detectable antibodies in most patients with erythema chronicum migrans is important to prevent late-stage neurologic, rheumatologic, and skin disorders.
Aavik, Einari   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy